EPISODE · Apr 20, 2026 · 17 MIN
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
from 1nessAgency Insights
The FDA's accelerated push to streamline biosimilar development and expand state drug importation programs in 2026 has opened a marketing opportunity most health systems haven't recognized: affordability messaging now belongs at the center of patient acquisition strategy, not buried in financial ass
What this episode covers
The FDA's accelerated push to streamline biosimilar development and expand state drug importation programs in 2026 has opened a marketing opportunity most health systems haven't recognized: affordability messaging now belongs at the center of patient acquisition strategy, not buried in financial ass
NOW PLAYING
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m